Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) Debt to Equity (2022 - 2026)

Core Laboratories filings provide 5 years of Debt to Equity readings, the most recent being $0.42 for Q1 2026.

  • On a quarterly basis, Debt to Equity fell 15.06% to $0.42 in Q1 2026 year-over-year; TTM through Mar 2026 was $0.42, a 15.06% decrease, with the full-year FY2025 number at $0.41, down 17.07% from a year prior.
  • Debt to Equity hit $0.42 in Q1 2026 for Core Laboratories, roughly flat from $0.41 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.94 in Q4 2022 to a low of $0.41 in Q4 2025.
  • Median Debt to Equity over the past 5 years was $0.55 (2024), compared with a mean of $0.6.
  • Biggest five-year swings in Debt to Equity: plummeted 31.25% in 2024 and later dropped 15.06% in 2026.
  • Core Laboratories' Debt to Equity stood at $0.94 in 2022, then dropped by 22.6% to $0.73 in 2023, then plummeted by 31.25% to $0.5 in 2024, then fell by 17.07% to $0.41 in 2025, then grew by 0.36% to $0.42 in 2026.
  • The last three reported values for Debt to Equity were $0.42 (Q1 2026), $0.41 (Q4 2025), and $0.42 (Q3 2025) per Business Quant data.